Back
CareDx 10K Form
Sell
35
CDNA
CareDx
Last Price:
$20.65
Seasonality Move:
-13.38%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CDNA News And Ratings
See the #1 stock for the next 7 days that we like better than CDNA
CDNA Financial Statistics
Sales & Book Value
| Annual Sales: | $280.3M |
|---|---|
| Cash Flow: | $10.8M |
| Price / Cash Flow: | 886.2 |
| Annual Sales: | $5.15 |
| Price / Book: | 4.05 |
Profitability
| EPS (TTM): | -2.69000 |
|---|---|
| Net Income (TTM): | $-143.6M |
| Gross Margin: | $178.3M |
| Return on Equity: | -49.52% |
| Return on Assets: | -30.36% |
CareDx Earnings Forecast
Key CareDx Financial Ratios
-
The Gross Profit Margin over the past 12 years for CDNA is 63.61%.
-
The Selling, General & Administrative Expenses for CDNA have been equal to 71.77% of Gross Profit Margin.
-
The Research & Development expenses have been 29.20% of Revenue.
-
The Interest Expense is -10.56% of Operating Income.
-
The Net Earning history of CDNA is -67.88% of Total Revenues.
-
Per Share Earnings over the last 12 years have been positive in 6 years.
CareDx Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CDNA |
| CUSIP: | 14167L |
| Website: | caredx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 4.1 |
| Quick Ratio: | 3.78 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 37.7 |